Please assess the completion status of the following clinical trial:

Trial Title: Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosed CAD (either SVD or MVD) with signs or symptoms of myocardial ischemia, scheduled for percutaneous revascularization are all candidates.~* Either native vessels and SVG can be included with de-novo or recurrent lesions.~* Lesions causing a diameter stenosis \>50% in a main coronary artery (LAD, RCA, LCx) or their principal branches (Dg, OM, PL, PDA).~Exclusion Criteria:~* Diabetes~* Age over 80 years old~* Recent Q wave myocardial infarction (less than 2 weeks)~* Severe hypertension, uncontrolled despite medical treatment~* Gastric ulcer or symptomatic gastritis~* Neoplasia~* Renal failure (creatinine \>2.5)~* Left main disease, or left main equivalent (proximal LAD and proximal LCx), or three vessel disease involving the proximal segments of the 3 main coronary branches~* Suboptimal angiographic result of PCI (DS% \>30% or TIMI flow \<grade 3)~* Contraindications to high-doses of steroids (immunosuppression, active infective disease, osteoporosis, recent use of high doses of steroids).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: SHAM_COMPARATOR): Bare Metal Stenting
- 2 (Type: ACTIVE_COMPARATOR): Stenting with DES
- 3 (Type: EXPERIMENTAL): Bare metal stenting and administration of prednisone

Based on this trial design, predict the completion outcome and termination type (if applicable).